Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Comparison of Outcomes Following Anterior vs Posterior Fusion Surgery for Patients With Degenerative Cervical Myelopathy: An Analysis From Quality Outcomes Database
Asher, Anthony L. , Devin, Clinton J. , Kerezoudis, Panagiotis , Chotai, Silky , Nian, Hui , Sivaganesan, Ahilan, McGirt, Matthew J., Archer, Kristin R. , Foley, Kevin T. , Mummaneni, Praveen V. , Bisson, Erica F. , Knightly, John J. , Shaffrey, Christopher I. , Bydon, Mohamad , Harrell, Frank E.

Mayo Clinic

Neurosurgery | March 25, 2018 | Volume: 84 | Issue: 4 | Pages: 919-926

10.1093/neuros/nyy144 | PMID 29741718 Get It

Abstract BACKGROUND The choice of anterior vs posterior approach for degenerative cervical myelopathy that spans multiple segments remains controversial. OBJECTIVE To compare the outcomes following the 2 approaches using multicenter prospectively collected data. METHODS Quality Outcomes Database (QOD) for patients undergoing surgery for 3 to 5 level degenerative cervical myelopathy was analyzed. The anterior group (anterior cervical discectomy [ACDF] or corpectomy [ACCF] with fusion) was compared with posterior cervical fusion. Outcomes included: patient reported outcomes (PROs): neck disability index (NDI), numeric rating scale (NRS) of neck pain and arm pain, EQ-5D, modified Japanese Orthopedic Association score for myelopathy (mJOA), and NASS satisfaction questionnaire; hospital length of stay (LOS), 90-d readmission, and return to work (RTW). Multivariable regression models were fitted for outcomes. RESULTS Of total 245 patients analyzed, 163 patients underwent anterior surgery (ACDF-116, ACCF-47) and 82 underwent posterior surgery. Patients undergoing an anterior approach had lower odds of having higher LOS ( P < .001, odds ratio 0.16, 95% confidence interval 0.08-0.30). The 12-mo NDI, EQ-5D, NRS, mJOA, and satisfaction scores as well as 90-d readmission and RTW did not differ significantly between anterior and posterior groups. CONCLUSION Patients undergoing anterior approaches for 3 to 5 level degenerative cervical myelopathy had shorter hospital LOS compared to those undergoing posterior decompression and fusion. Also, patients in both groups exhibited similar long-term PROs, readmission, and RTW rates. Further investigations are needed to compare the differences in longer term reoperation rates and functional outcomes before the clinical superiority of one approach over the other can be established.
Initial Experience of Tomosynthesis-Guided Vacuum-Assisted Biopsies of Tomosynthesis-Detected (2D Mammography and Ultrasound Occult) Architectural Distortions
Patel, Bhavika , Pizzitola, Victor J. , Lorans, Roxanne, Giurescu, Marina E., Eversman, William G. , Lewin, John, Covington, Matthew, Giurescu, Marina, Eversman, William, Patel, Bhavika K , Covington, Matthew F.

Mayo Clinic

American Journal of Roentgenology | March 23, 2018 | Volume: 210 | Issue: 6 | Pages: 1395-1400

10.2214/ajr.17.18802 | PMID 29570367 Get It

Localization and functional consequences of a direct interaction between TRIOBP-1 and hERG proteins in the heart
Jones, David K., Johnson, Ashley , Roti, Elon C. Roti , Uelmen, Rebecca , Ayers, Rebecca A., Baczkó, István , Tester, David J. , Ackerman, Michael J. , Robertson, Gail A. , Roti Roti, Elon C , Uelmen, Rebecca , Robertson, Gail A , Jones, David K., Liu, Fang , Trudeau, Matthew C.

Mayo Clinic

Journal of Cell Science | March 22, 2018 | Volume: 131 | Issue: 6 | Pages: No page available

10.1242/jcs.206730 | PMID 29507111 Get It

ABSTRACT Reduced levels of the cardiac human (h)ERG ion channel protein and the corresponding repolarizing current IKr can cause arrhythmia and sudden cardiac death, but the underlying cellular mechanisms controlling hERG surface expression are not well understood. Here, we identified TRIOBP-1, an F-actin-binding protein previously associated with actin polymerization, as a putative hERG-interacting protein in a yeast-two hybrid screen of a cardiac library. We corroborated this interaction by performing Förster resonance energy transfer (FRET) in HEK293 cells and co-immunoprecipitation in HEK293 cells and native cardiac tissue. TRIOBP-1 overexpression reduced hERG surface expression and current density, whereas reducing TRIOBP-1 expression via shRNA knockdown resulted in increased hERG protein levels. Immunolabeling in rat cardiomyocytes showed that native TRIOBP-1 colocalized predominantly with myosin-binding protein C and secondarily with rat ERG. In human stem cell-derived cardiomyocytes, TRIOBP-1 overexpression caused intracellular co-sequestration of hERG signal, reduced native IKr and disrupted action potential repolarization. Ca2+ currents were also somewhat reduced and cell capacitance was increased. These findings establish that TRIOBP-1 interacts directly with hERG and can affect protein levels, IKr magnitude and cardiac membrane excitability.
Effect of Postoperative Mechanical Axis Alignment on Survival and Functional Outcomes of Modern Total Knee Arthroplasties with Cement
Abdel, Matthew P. , Ollivier, Matthieu , Parratte, Sébastien , Trousdale, Robert T. , Berry, Daniel J. , Pagnano, Mark W. , Abdel, Matthew P , Berry, Daniel J

Mayo Clinic

Journal of Bone and Joint Surgery | March 21, 2018 | Volume: 100 | Issue: 6 | Pages: 472-478

10.2106/jbjs.16.01587 | PMID 29557863 Get It

Abstract: We previously compared the 15-year survivorship of total knee arthroplasty (TKA) implants that were mechanically aligned (0° ± 3° relative to the mechanical axis) compared with those that were outside that range and considered outliers. The original publication included 398 TKAs (292 in the aligned group and 106 in the outlier group) performed from 1985 to 1990. At the time of follow-up in the previous study, 138 patients (155 TKAs) had died and 59 knees had been revised. Since that publication, 49 additional patients (87 knees) have died. At 20 years, 57 (19.5%) of the 292 knees in the mechanically aligned group had been revised compared with 16 (15.1%) of the 106 knees in the outlier group (p = 0.97). Postoperative alignment within 0° ± 3° of the mechanical axis did not provide a functional advantage at 1, 5, 10, 15, and/or 20 years postoperatively as demonstrated by the Knee Society scores being similar between the groups (p ≥ 0.2 at all intervals). At 20 years, we once again did not find that neutral mechanical alignment provided better implant survivorship than that found in the outlier group. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer Screening
Resnick, Matthew J., Graves, Amy J., Thapa, Sunita, Gambrel, Robert, Tyson, Mark D. , Buntin, Melinda Beeuwkes, Penson, David F. , Lee, Daniel

Mayo Clinic

JAMA Internal Medicine | March 19, 2018 | Volume: 178 | Issue: 5 | Pages: 648

10.1001/jamainternmed.2017.8087 | PMID 29554179 Get It

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Major-Monfried, Hannah , Renteria, Anne S. , Pawarode, Attaphol , Reddy, Pavan , Ayuk, Francis , Holler, Ernst , Efebera, Yvonne A. , Wölfl, Matthias , Wudhikarn, Kitsada , Ordemann, Rainer, Young, Rachel , Hartwell, Matthew J. , Chaudhry, Mohammed S., Aziz, Mina, Etra, Aaron , Yanik, Gregory A. , Kröger, Nicolaus , Weber, Daniela , Chen, Yi‐Bin , Nakamura, Ryotaro , Rösler, Wolf, Kitko, Carrie L. , Harris, Andrew C. , Kowalyk, Steven, Morales, George , Torres, I.M., Özbek, Umut , Ferrara, James L.M. , Levine, John E. , Kroger, Nicolaus , Kroger, Nicolaus , Levine, John E , Hogan, William J. , Qayed, Muna , Hexner, Elizabeth O. , Shah, Jay Narayan , Pulsipher, Michael A. , Reshef, Ran , Kröger, Nicolaus

Mayo Clinic

Blood | March 15, 2018 | Volume: 131 | Issue: 25 | Pages: 2846-2855

10.1182/blood-2018-01-822957 | PMID 29545329 Get It

Key Points Biomarker scores generated after 1 week of steroid treatment of GVHD are prognostic. Biomarkers reflect prognosis better than early clinical response to GVHD treatment.
Lightweight, compact, and high‐performance 3T MR system for imaging the brain and extremities
Foo, Thomas , Laskaris, E.T., Vermilyea, Mark, Xu, Minfeng , Thompson, Paul, Conte, Gene, Epps, Christopher Van, Immer, Christopher, Tan, Ek T. , Graziani, Dominic, Mathieu, Jean‐Baptise, Hardy, Christopher J., Schenck, John F., Fiveland, Eric, Stautner, Wolfgang , Ricci, Justin, Piel, Joseph E., Park, Keith, Hua, Yihe , Bai, Ye , Kagan, Alex, Stanley, David A. , Weavers, Paul T., Gray, Erin M. , Shu, Yunhong , Frick, Matthew A., Trzasko, Joshua D. , Foo, Thomas K F , Tan, Ek T , Gray, Erin, Trzasko, Joshua, Bernstein, Matt A , Thompson, Paul, Epps, Chris Van, Lee, Seung‐Kyun , Campeau, Norbert G. , Huston, John , Bernstein, Matt A.

Mayo Clinic

Magnetic Resonance in Medicine | March 15, 2018 | Volume: 80 | Issue: 5 | Pages: 2232-2245

10.1002/mrm.27175 | PMID 29536587 Get It

PurposeTo build and evaluate a small‐footprint, lightweight, high‐performance 3T MRI scanner for advanced brain imaging with image quality that is equal to or better than conventional whole‐body clinical 3T MRI scanners, while achieving substantial reductions in installation costs.MethodsA conduction‐cooled magnet was developed that uses less than 12 liters of liquid helium in a gas‐charged sealed system, and standard NbTi wire, and weighs approximately 2000 kg. A 42‐cm inner‐diameter gradient coil with asymmetric transverse axes was developed to provide patient access for head and extremity exams, while minimizing magnet‐gradient interactions that adversely affect image quality. The gradient coil was designed to achieve simultaneous operation of 80‐mT/m peak gradient amplitude at a slew rate of 700 T/m/s on each gradient axis using readily available 1‐MVA gradient drivers.ResultsIn a comparison of anatomical imaging in 16 patients using T2‐weighted 3D fluid‐attenuated inversion recovery (FLAIR) between the compact 3T and whole‐body 3T, image quality was assessed as equivalent to or better across several metrics. The ability to fully use a high slew rate of 700 T/m/s simultaneously with 80‐mT/m maximum gradient amplitude resulted in improvements in image quality across EPI, DWI, and anatomical imaging of the brain.ConclusionsThe compact 3T MRI system has been in continuous operation at the Mayo Clinic since March 2016. To date, over 200 patient studies have been completed, including 96 comparison studies with a clinical 3T whole‐body MRI. The increased gradient performance has reliably resulted in consistently improved image quality.
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients
Kalli, Kimberly R., Block, Matthew S. , Kasi, Pashtoon Murtaza , Erskine, Courtney L. , Hobday, Timothy J. , Dietz, Allan B. , Padley, Douglas, Gustafson, Michael P. , Shreeder, Barath , Puglisi-Knutson, Danell, Visscher, Dan W., Mangskau, Toni K., Wilson, G. Haswell , Knutson, Keith L. , Kasi, Pashtoon M, Dietz, Allan, Kasi, Pashtoon Murtaza , Dietz, Allan B , Knutson, Keith L.

Mayo Clinic

Clinical Cancer Research | March 15, 2018 | Volume: 24 | Issue: 13 | Pages: 3014-3025

10.1158/1078-0432.ccr-17-2499 | PMID 29545464 Get It

Abstract Purpose: Folate receptor alpha (FR) is overexpressed in several cancers. Endogenous immunity to the FR has been demonstrated in patients and suggests the feasibility of targeting FR with vaccine or other immune therapies. CD4 helper T cells are central to the development of coordinated immunity, and prior work shows their importance in protecting against relapse. Our previous identification of degenerate HLA-class II epitopes from human FR led to the development of a broad coverage epitope pool potentially useful in augmenting antigen-specific immune responses in most patients. Patients and Methods: We conducted a phase I clinical trial testing safety and immunogenicity of this vaccine, enrolling patients with ovarian cancer or breast cancer who completed conventional treatment and who showed no evidence of disease. Patients were initially treated with low-dose cyclophosphamide and then vaccinated 6 times, monthly. Immunity and safety were examined during the vaccine period and up to 1 year later. Results: Vaccination was well tolerated in all patients. Vaccine elicited or augmented immunity in more than 90% of patients examined. Unlike recall immunity to tetanus toxoid (TT), FR T-cell responses developed slowly over the course of vaccination with a median time to maximal immunity in 5 months. Despite slow development of immunity, responsiveness appeared to persist for at least 12 months. Conclusions: The results demonstrate that it is safe to augment immunity to the FR tumor antigen, and the developed vaccine is testable for therapeutic activity in most patients whose tumors express FR, regardless of HLA genotype. Clin Cancer Res; 24(13); 3014–25. ©2018 AACR.
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Kurokawa, Cheyne, Iankov, Ianko, Anderson, S. Keith , Aderca, Ileana, Leontovich, Alexey A. , Oberg, Ann L. , Greiner, Suzanne , Becker, Marc A., Thompson, E. Aubrey , Haluska, Paul , Jentoft, Mark E. , Weroha, S. John , Jen, Jin , Iankov, Ianko D, Schroeder, Mark A. , Greiner, Suzanne M, Galanis, Evanthia , Maurer, Matthew J. , Giannini, Caterina , Parney, Ian F. , Sarkaria, Jann N.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 6, 2018 | Volume: 110 | Issue: 10 | Pages: 1123-1132

10.1093/jnci/djy033 | PMID 29788332 Get It

Team Approach: Complex Dermal Wound-Healing Utilizing Negative-Pressure Wound Therapy (NPWT) in Orthopaedic Trauma
Green, Tyson , Kavros, Steven J., Springer, Steve, Drez, David, Gremillion, Jared, Kavros, Steven, McCabe, Matthew

Mayo Clinic

JBJS Reviews | March 6, 2018 | Volume: 6 | Issue: 3 | Pages: e1-e1

10.2106/jbjs.rvw.17.00042 | PMID 29509555 Get It

* Repairing skin and soft-tissue loss after severe trauma remains a daunting task because of the complications that arise throughout treatment. Negative-pressure wound therapy (NPWT) has proven to be a useful tool for reducing these complications by facilitating the repair of damaged soft tissue in a variety of scenarios and settings. * The success of NPWT depends on negative pressure, controlling local edema, the removal of inflammatory mediators, revascularization and granulation, and reducing the wound-bed bioburden. * NPWT is a reasonable treatment modality when used appropriately according to recommended indications. * NPWT creates an environment that can help to accelerate healing after devastating soft-tissue loss. * With a high reported rate of success, NPWT can be used in a variety of settings. * NPWT has proven to be useful in conjunction with flaps and grafts to further aid the practitioner in repairing damaged tissue. * NPWT has the potential of eliminating additional surgical procedures and lengthy hospital stays, thus reducing unnecessary costs.